InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $3.990 0.12 (2.92%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,400 EGM presentation and Chair's address 22 Jan 2024 9:05AM $0.620 $3.990 risen by 543.55%
$2,400 4DMedical and Philips formalise MOU with Teaming Agreement 22 Jan 2024 9:01AM $0.620 $3.990 risen by 543.55%
$2,400 4DMedical webinar with Dr David Shulkin 15 Jan 2024 4:41PM $0.625 $3.990 risen by 538.40%
$2,400 Notice of Extraordinary General Meeting and Proxy Form 22 Dec 2023 9:04AM $0.715 $3.990 risen by 458.04%
$2,400 Change in substantial holding 19 Dec 2023 3:57PM $0.705 $3.990 risen by 465.96%
$2,400 Change in substantial holding 19 Dec 2023 3:56PM $0.705 $3.990 risen by 465.96%
$2,400 Change in substantial holding 19 Dec 2023 3:54PM $0.705 $3.990 risen by 465.96%
$2,400 4DMedical completes acquisition of Imbio 18 Dec 2023 10:02AM $0.740 $3.990 risen by 439.19%
$2,400 Cleansing Notice 15 Dec 2023 1:03PM $0.745 $3.990 risen by 435.57%
$2,400 Application for quotation of securities - 4DX 14 Dec 2023 9:15AM $0.735 $3.990 risen by 442.86%
$2,400 Prospectus 11 Dec 2023 1:14PM $0.810 $3.990 risen by 392.59%
$2,400 Proposed issue of securities - 4DX 11 Dec 2023 9:33AM $0.955 $3.990 risen by 317.80%
$2,400 Proposed issue of securities - 4DX 11 Dec 2023 9:33AM $0.955 $3.990 risen by 317.80%
$2,400 Investor Presentation Imbio acquisition and capital raise 11 Dec 2023 9:33AM $0.955 $3.990 risen by 317.80%
$2,400 4DMedical acquires Imbio and completes equity raising 11 Dec 2023 9:33AM $0.955 $3.990 risen by 317.80%
$2,400 Trading Halt 7 Dec 2023 8:51AM $0.955 $3.990 risen by 317.80%
$2,400 S&P DJI Announces December 2023 Quarterly Rebalance 1 Dec 2023 5:09PM $0.970 $3.990 risen by 311.34%
$2,400 Webinar presentation 1 Dec 2023 9:51AM $0.955 $3.990 risen by 317.80%
$2,400 4DMedical Webinar 30 Nov 2023 2:55PM $0.970 $3.990 risen by 311.34%
$2,400 4DMedical and Philips sign Memorandum of Understanding 29 Nov 2023 9:35AM $0.920 $3.990 risen by 333.70%
$2,400 Application for quotation of securities - 4DX 24 Nov 2023 1:57PM $0.920 $3.990 risen by 333.70%
$2,400 4DX signs SaaS contracts to expand into Detroit & Memphis 22 Nov 2023 8:52AM $0.670 $3.990 risen by 495.52%
$2,400 4DMedical receives U.S. FDA clearance for CT LVAS 20 Nov 2023 9:05AM $0.655 $3.990 risen by 509.16%
$2,400 Presentation to Bell Potter Healthcare Conference 13 Nov 2023 6:39PM $0.785 $3.990 risen by 408.28%
$2,400 U.S. CMS Approves Reimbursement for 4DMedical 13 Nov 2023 8:59AM $0.460 $3.990 risen by 767.39%

326 - 350 of 597 results

Page 14 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.